Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Prognostic Impacts of Next-Generation Sequencing-Based Measurable Residual Disease Monitoring before and after Allogeneic Hematopoietic Cell Transplantation in AML

Byung Sik Cho, MD, PhD, Dain Kang, Hoon Seok Kim, Heeje Kim, MD PhD, Myungshin Kim, MD PhD, Yonggoo Kim

Blood (2020) 136 (Supplement 1): 1–2.

https://doi.org/10.1182/blood-2020-140710

Published: 2020

Journal Articles

A Phase 3 Trial of Thymoglobuline for Prevention of Chronic Gvhd in Transplantation from an HLA-Matched Sibling

Gi June Min, MD, Byung Sik Cho, MD, PhD, Sung-Soo Park, MD, PhD, Silvia Park, MD PhD, Seung-Ah Yahng, MD, PhD, Young-Woo Jeon, MD PhD, Seung-Hwan Shin, MD, Jae-Ho Yoon, MD PhD, Sung-Eun Lee, MD PhD, Ki-Seong Eom, MD, PhD, Yoo-Jin Kim, MD, PhD, Chang-Ki Min, MD PhD, Seok-Goo Cho, MD, PhD, Dong-Wook Kim, MD, Jong Wook Lee, MD, PhD, Heeje Kim, MD PhD, Seok Lee, MD, PhD

Blood (2020) 136 (Supplement 1): 32.

https://doi.org/10.1182/blood-2020-139234

Published: 2020

Journal Articles

Measurable Residual Disease Assay with WT1 Expression in Acute Myeloid Leukemia Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation; Optimal Threshold, Time Points, and Candidates

Byung Sik Cho, MD PhD, GI June MIN, MD, Heeje Kim, MD PhD, Seug Yun Yoon, MD, Sung-Soo Park, MD, Silvia Park, MD PhD, Seung-Ah Yahng, MD PhD, Young-Woo Jeon, MD PhD, Seung-Hwan Shin, MD PhD, Jae-Ho Yoon, MD PhD, Sung-Eun Lee, MD PhD, Ki-Seong Eom, MD PhD, Yoo-Jin Kim, MD PhD, Seok Lee, MD PhD, Chang-Ki Min, MD PhD, Seok-Goo Cho, MD PhD, Dong-Wook Kim, MD PhD, Jong-Wook Lee, MD PhD

Blood (2018) 132 (Supplement 1): 2759.

https://doi.org/10.1182/blood-2018-99-110042

Published: 2018

Journal Articles

Specific Donor Human Leukocyte Antigen (HLA) Allotypes and CMV IgG Serology Status Predict the Risk of Cytomegalovirus-Related Disease in Acute Myeloid Leukemia Patients Who Received Allogeneic Hematopoietic Stem Cell Transplantation

Blood (2018) 132 (Supplement 1): 2076.

https://doi.org/10.1182/blood-2018-99-113233

Published: 2018

Journal Articles

Improved Survival Outcomes By Iron Chelating Therapy with Deferasirox after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia

Byung Sik Cho, MD PhD, Young-Woo Jeon, MD, Sung-Soo Park, Jae-Ho Yoon, MD PhD, Sung-Eun Lee, MD, Ki-Seong Eom, Yoo-Jin Kim, MD PhD, Seok Lee, MD PhD, Chang-Ki Min, MD PhD, Seok-Goo Cho, MD PhD, Dong-Wook Kim, MD PhD, Jong-Wook Lee, MD, Woo-Sung Min, Heeje Kim, MD PhD

Blood (2017) 130 (Supplement 1): 3207.

https://doi.org/10.1182/blood.V130.Suppl_1.3207.3207

Published: 2017

Journal Articles

Development of Prognostic Prediction Model for Decision of Secondary Allogeneic Stem Cell Transplantation for Relapsed Acute Myeloid Leukemia after First Stem Cell Transplantation

Sung-Soo Park, Heeje Kim, MD PhD, Dae Hun Kwak, Gi June Min, MD, Young-Woo Jeon, MD, Jae-Ho Yoon, MD PhD, Seung-Hwan Shin, Seung-Ah Yahng, Sung-Eun Lee, MD, Byung-Sik Cho, MD, Ki-Seong Eom, Yoo-Jin Kim, MD PhD, Seok Lee, Chang-Ki Min, MD, Seok-Goo Cho, Dong-Wook Kim, MD PhD, Jong-Wook Lee, MD, Woo-Sung Min

Blood (2017) 130 (Supplement 1): 3279.

https://doi.org/10.1182/blood.V130.Suppl_1.3279.3279

Published: 2017

Journal Articles

Long-Term Follow-up on Adult Patients with Philadelphia-Chromosome Positive Acute Myeloid Leukemia Who Were Treated with Interim Imatinib Followed By Allogeneic Hematopoietic Cell Transplantation

Heeje Kim, MD PhD, Gi June Min, MD, Jae-Ho Yoon, MD PhD, Sung-Soo Park, Young-Woo Jeon, MD, Sung-Eun Lee, MD, Byung-Sik Cho, MD, Ki-Sung Eom, Yoo-Jin Kim, MD PhD, Seok Lee, Chang-Ki Min, MD, Seok-Goo Cho, Dong-Wook Kim, MD PhD, Jong-Wook Lee, MD, Woo-Sung Min

Blood (2017) 130 (Supplement 1): 2030.

https://doi.org/10.1182/blood.V130.Suppl_1.2030.2030

Published: 2017

Journal Articles

Morphological Subtype According to the FAB Classification Correlates with Molecular Subtype Using Genomic Risk Classification Based on Somatic Mutation Profiles in Normal Karyotype AML

Blood (2017) 130 (Supplement 1): 5075.

https://doi.org/10.1182/blood.V130.Suppl_1.5075.5075

Published: 2017

Journal Articles

Replication of New Genomic Classification System in Acute Myeloid Leukemia with Normal Karyotype

Blood (2016) 128 (22): 2876.

https://doi.org/10.1182/blood.V128.22.2876.2876

Published: 2016

Journal Articles

RUNX1 Mutation in Cytogenetically Normal Acute Myeloid Leukemia : Clinical Implications, Co-Mutation Analysis

Blood (2016) 128 (22): 5253.

https://doi.org/10.1182/blood.V128.22.5253.5253

Published: 2016

Journal Articles

Longitudinal Tracking of MDS Patients Using Next Generation Sequencing Provides a Predictive Measure for Azacitidine Response and AML Progression

Blood (2016) 128 (22): 52.

https://doi.org/10.1182/blood.V128.22.52.52

Published: 2016

Journal Articles

5-Hydroxymethylcytosine Is Correlated with TET2 or IDH1/2 Mutations However, May Not be a Prognostic Value to Predict the Survivals in Normal Karyotype AML

Jae-Sook Ahn, MDPhD, Hyeoung-Joon Kim, MD PhD, Yeo-Kyeoung Kim, MD, PhD, Seung-Shin Lee, MD, Sung-Hoon Jung, MD PhD, Deok-Hwan Yang, MD PhD, Je-Jung Lee, Park Hee Jeong, Seung Hyun Choi, PhD, Chul Won Jung, MD PhD, Jun-Ho Jang, MD PhD, Heeje Kim, MD PhD, Joon Ho Moon, MD, PhD, Sang Kyun Sohn, MD PhD, Sung-Hyun Kim, Dennis Dong Hwan Kim, MD PhD

Blood (2015) 126 (23): 3832.

https://doi.org/10.1182/blood.V126.23.3832.3832

Published: 2015

Journal Articles

Molecular and Cytogenetic Risk Stratification For Core-Binding Factor-Positive Adult AML With Analysis Of Post-Remission Treatment Outcomes Including Transplantation

Jae-Ho Yoon, MD, Heeje Kim, MD, PhD, Seung-Hwan Shin, Young-Woo Jeon, Jung-Ho Kim, Sung-Eun Lee, Byung-Sik Cho, MD, PhD, Ki-Seong Eom, Yoo-Jin Kim, Seok Lee, MD, PhD, Chang-Ki Min, Seok-Goo Cho, Dong-Wook Kim, Jong-Wook Lee, Woo-Sung Min, Chong-Won Park

Blood (2013) 122 (21): 1301.

https://doi.org/10.1182/blood.V122.21.1301.1301

Published: 2013

Journal Articles

Full Haplotype Mismatch Stem Cell Transplantation: Myeloablative with T-Cell Depletion Vs. Reduced Intensity Conditioning without T-Cell Depletion

Heeje Kim, MD, PhD, Woo-Sung Min, MD, PhD, Ki-Seong Eom, MD, PhD, Byung-Sik Cho, MD, Seung-Ah Yahng, MD, Sung-Eun Lee, MD, Yoo-Jin Kim, MD, Seok Lee, MD, PhD, Chang-Ki Min, MD, PhD, Seok-Goo Cho, MD, PhD, Jong-Wook Lee, MD, PhD, Chong-Won Park, MD, PhD

Blood (2010) 116 (21): 3533.

https://doi.org/10.1182/blood.V116.21.3533.3533

Published: 2010

Journal Articles

Killer Cell Immunoglobulin-Like Receptor (KIR) Ligands Predict Outcomes of Autologous Stem Cell Transplantation for AML

Heeje Kim, MD, PhD, Tae-Hyang Lee, MS, So-Hye Park, MS, Hyun-Jeong Sohn, PhD, Hee-Baeg Choi, PhD, Yoo-Jin Kim, MD, PhD, Tai-Gyu Kim, MD, PhD, Woo-Sung Min, MD, PhD

Blood (2010) 116 (21): 3571.

https://doi.org/10.1182/blood.V116.21.3571.3571

Published: 2010

Journal Articles

Comparative 2-Arm Study for Acute Graft-Versus-Host Disease; Antithymocyte Globulin Is More Effective Than Mycofenolate Mofetil on Outcome of Allogeneic Peripheral Blood Stem Cell Transplantation from Mismatched Unrelated Donors.

Woo-Sung Min, MD, PhD, Heeje Kim, MD, PhD, Byoung-Sik Cho, MD, Sung-Yong Kim, MD, Ki-Sung Eom, MD, Chang-Ki Min, MD, PhD, Seok Lee, MD, PhD, Jong-Wook Lee, MD, PhD, Chong-Won Park, MD, PhD, Chun-Choo Kim, MD, PhD

Blood (2006) 108 (11): 5395.

https://doi.org/10.1182/blood.V108.11.5395.5395

Published: 2006

Journal Articles

High Level of Pretransplant Leukemic Blasts and the Absence of Chronic Graft-Versus-Host Disease Provide Negative Effects on Clinical Outcome of Transplantation with Fludarabine-Busulfex Based Reduced Intensity Conditioning for Patients with the De Novo Myelodysplastic Syndrome According to WHO Criteria.

Seok-Goo Cho, MD, PhD, Byung-Sik Cho, MD, Yoo-Jin Kim, MD, PhD, Sung-Yong Kim, MD, PhD, Ki-Seong Eom, MD, PhD, HeeJe Kim, MD, PhD, Seok Lee, MD, PhD, Chang-Ki Min, MD, PhD, Dong-Wook Kim, MD, PhD, Jong-Wook Lee, MD, PhD, Woo-Sung Min, MD, PhD, Chun-Choo Kim, MD, PhD

Blood (2006) 108 (11): 4862.

https://doi.org/10.1182/blood.V108.11.4862.4862

Published: 2006

NARROW

Prognostic Impacts of Next-Generation Sequencing-Based Measurable Residual Disease Monitoring before and after Allogeneic Hematopoietic Cell Transplantation in AML

A Phase 3 Trial of Thymoglobuline for Prevention of Chronic Gvhd in Transplantation from an HLA-Matched Sibling

Measurable Residual Disease Assay with WT1 Expression in Acute Myeloid Leukemia Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation; Optimal Threshold, Time Points, and Candidates

Specific Donor Human Leukocyte Antigen (HLA) Allotypes and CMV IgG Serology Status Predict the Risk of Cytomegalovirus-Related Disease in Acute Myeloid Leukemia Patients Who Received Allogeneic Hematopoietic Stem Cell Transplantation

Improved Survival Outcomes By Iron Chelating Therapy with Deferasirox after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia

Development of Prognostic Prediction Model for Decision of Secondary Allogeneic Stem Cell Transplantation for Relapsed Acute Myeloid Leukemia after First Stem Cell Transplantation

Long-Term Follow-up on Adult Patients with Philadelphia-Chromosome Positive Acute Myeloid Leukemia Who Were Treated with Interim Imatinib Followed By Allogeneic Hematopoietic Cell Transplantation

Morphological Subtype According to the FAB Classification Correlates with Molecular Subtype Using Genomic Risk Classification Based on Somatic Mutation Profiles in Normal Karyotype AML

Replication of New Genomic Classification System in Acute Myeloid Leukemia with Normal Karyotype

RUNX1 Mutation in Cytogenetically Normal Acute Myeloid Leukemia : Clinical Implications, Co-Mutation Analysis

Longitudinal Tracking of MDS Patients Using Next Generation Sequencing Provides a Predictive Measure for Azacitidine Response and AML Progression

5-Hydroxymethylcytosine Is Correlated with TET2 or IDH1/2 Mutations However, May Not be a Prognostic Value to Predict the Survivals in Normal Karyotype AML

Molecular and Cytogenetic Risk Stratification For Core-Binding Factor-Positive Adult AML With Analysis Of Post-Remission Treatment Outcomes Including Transplantation

Full Haplotype Mismatch Stem Cell Transplantation: Myeloablative with T-Cell Depletion Vs. Reduced Intensity Conditioning without T-Cell Depletion

Killer Cell Immunoglobulin-Like Receptor (KIR) Ligands Predict Outcomes of Autologous Stem Cell Transplantation for AML

Comparative 2-Arm Study for Acute Graft-Versus-Host Disease; Antithymocyte Globulin Is More Effective Than Mycofenolate Mofetil on Outcome of Allogeneic Peripheral Blood Stem Cell Transplantation from Mismatched Unrelated Donors.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only